FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8  |  FHIR Version n/a  User: [n/a]

377381003: Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1202699010 Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule (product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1215588019 Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1478744012 Acetaminophen+phenyltoloxamine citrate+salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
2820832014 Paracetamol + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
3469707018 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3469708011 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3469709015 Product containing acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3469710013 Product containing paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3490467019 Product containing paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3569299017 Product containing only paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3569300013 Product containing only acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3569301012 Product containing only paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3681519012 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681520018 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681521019 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681522014 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing phenyltoloxamine (medicinal product) false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Acetaminophen compound preparation false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Ethanolamine false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Sedating antihistamine false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Non-opioid analgesic (substance) false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Phenyltoloxamine (substance) false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing paracetamol and phenyltoloxamine citrate and salicylamide false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Phenyltoloxamine citrate false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Salicylamide false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Paracetamol false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form Capsule false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Cardiovascular agent (substance) false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form Oral capsule true Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Paracetamol false Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Paracetamol false Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 300 (kwalificatiewaarde) false Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value 1 (kwalificatiewaarde) false Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value 1 (kwalificatiewaarde) false Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value 1 (kwalificatiewaarde) false Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Phenyltoloxamine citrate false Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Phenyltoloxamine citrate false Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 20 (kwalificatiewaarde) false Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient Salicylamide false Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Salicylamide false Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 200 (kwalificatiewaarde) false Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Salicylamide false Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Phenyltoloxamine citrate false Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Paracetamol false Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient 3 (kwalificatiewaarde) false Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Salicylamide true Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Phenyltoloxamine citrate true Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Paracetamol true Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Salicylamide true Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Paracetamol true Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Phenyltoloxamine citrate true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start